Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · IEX Real-Time Price · USD
0.179
0.00 (-0.06%)
Jul 19, 2024, 4:00 PM EDT - Market closed
MTNB Market Cap
MTNB has a market cap or net worth of $44.97 million as of July 22, 2024. Its market cap has decreased by -39.64% in one year.
Market Cap
44.97M
Enterprise Value
40.21M
1-Year Change
-39.64%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $44.97M, a decrease of -79.88%. That is a compound annual growth rate of -19.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 44.90M | -4.26% |
| Dec 29, 2023 | 46.90M | -56.73% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
| Mar 2, 2017 | 223.50M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 45.92M |
| Kezar Life Sciences | 45.87M |
| Daxor | 45.85M |
| Carisma Therapeutics | 45.70M |
| Marker Therapeutics | 45.00M |
| Lucid Diagnostics | 44.71M |
| Regencell Bioscience Holdings | 44.50M |
| CalciMedica | 44.40M |